Once the tumors had reached palpable size (averaging 150 mm2), anti-EphA2-IR700 dye conjugate was administered and tracked for accumulation within the tumor by fluorescence imaging over 48 h post administration (Fig. 1C). Here, EPHA2 is linked to neoplasm.